Sepsis: frontiers in supportive care, organisation and research (Q38764864)

6 September 2017

title

Sepsis: frontiers in supportive care, organisation and research (English)

1 reference

6 September 2017

0 references

7

1 reference

6 September 2017

Anders Perner

1

0 references

Derek C. Angus

4

object named as

Derek C Angus

1 reference

6 September 2017

Andrew Rhodes

2

0 references

author name string

Bala Venkatesh

3

1 reference

6 September 2017

Ignacio Martin-Loeches

5

1 reference

6 September 2017

Jean-Charles Preiser

6

1 reference

6 September 2017

John Marshall

8

1 reference

6 September 2017

Konrad Reinhart

9

1 reference

6 September 2017

Michael Joannidis

10

1 reference

6 September 2017

Steven M Opal

11

1 reference

6 September 2017

language of work or name

1 reference

27 January 2017

1 reference

6 September 2017

published in

Intensive Care Medicine

1 reference

6 September 2017

volume

43

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

496-508

1 reference

Sepsis-The Final Common Pathway to Death From Multiple Organ Failure in Infection

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Increased 1-year healthcare use in survivors of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Management of severe sepsis: advances, challenges, and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

The Effect of High-Flow Nasal Cannula Oxygen Therapy on Mortality and Intubation Rate in Acute Respiratory Failure: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Asynchronies during mechanical ventilation are associated with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Scandinavian clinical practice guideline on mechanical ventilation in adults with the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Driving pressure and survival in the acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

From protective ventilation to super-protective ventilation for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Challenges for the endocrine laboratory in critical illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Adrenocortical (dys)function in septic shock - a sick euadrenal state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Increased mortality associated with growth hormone treatment in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Developing a clinically feasible personalized medicine approach to pediatric septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease Severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Understanding acute kidney injury in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Fluid challenges in intensive care: the FENICE study: A global inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

High versus Low Blood-Pressure Target in Patients with Septic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Postoperative blood pressure deficit and acute kidney injury progression in vasopressor-dependent cardiovascular surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Quantifying Glomerular Filtration Rates in Acute Kidney Injury: A Requirement for Translational Success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Management of renal replacement therapy in ICU patients: an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Patient Selection and Timing of Continuous Renal Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Early versus Late Parenteral Nutrition in Critically Ill Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Metabolic response to the stress of critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Early versus Late Parenteral Nutrition in Critically Ill Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

A randomized trial of glutamine and antioxidants in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Immunotherapy for sepsis--a new approach against an ancient foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Infections associated with haemophagocytic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Clinical review: blood purification for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

An extracorporeal blood-cleansing device for sepsis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Parallels between cancer and infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

A Review of GM-CSF Therapy in Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

New approaches to sepsis: molecular diagnostics and biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Sepsis: a roadmap for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Biotechnology and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Hospital Incidence and Mortality Rates of Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Differences in Impact of Definitional Elements on Mortality Precludes International Comparisons of Sepsis Epidemiology-A Cohort Study Illustrating the Need for Standardized Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Lower versus higher hemoglobin threshold for transfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Albumin replacement in patients with severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4677-4

Patient-ventilator asynchrony

21 January 2018

1 reference

12 December 2020

Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials

1 reference

12 December 2020

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock

1 reference

12 December 2020

The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock

1 reference

12 December 2020

Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*

1 reference

12 December 2020

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients

1 reference

12 December 2020

High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis

1 reference

12 December 2020

Long-term outcome and quality-adjusted life years after severe sepsis

1 reference

12 December 2020

Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes

1 reference

12 December 2020

Sepsis and septic shock

1 reference

12 December 2020

Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study*

1 reference

12 December 2020

10.1007/S00134-017-4677-4

Identifiers

DOI

1 reference

6 September 2017

1 reference